Closure of the Pancreatic Remnant after Distal Pnacreatectomy A prospective randomized controlled trial
Completed
- Conditions
- chronic pancreatitis, cystic pancreatic lesions, malignant pancreatic lesions and neuroendocrine tumors located in the body or tail of the pancreas.
- Registration Number
- NL-OMON24836
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
Age above 18 years
- Expected survival time more than 12 months
Exclusion Criteria
- Current immunosuppresive therapy
- Chemotherapy within 2 weeks before operation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method development of pancreatic fistula
- Secondary Outcome Measures
Name Time Method mortality<br /><br>morbidity<br /><br>costs